BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9103518)

  • 1. Nonstriatal dopamine D1 receptors regulate striatal acetylcholine release in vivo.
    Acquas E; Wilson C; Fibiger HC
    J Pharmacol Exp Ther; 1997 Apr; 281(1):360-8. PubMed ID: 9103518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic regulation of striatal acetylcholine release: importance of D1 and N-methyl-D-aspartate receptors.
    Damsma G; Robertson GS; Tham CS; Fibiger HC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1064-72. PubMed ID: 1837058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
    DeBoer P; Abercrombie ED
    J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that neuroleptics increase striatal acetylcholine release through stimulation of dopamine D1 receptors.
    Imperato A; Obinu MC; Casu MA; Mascia MS; Dazzi L; Gessa GL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):557-62. PubMed ID: 8102643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic regulation of striatal acetylcholine release: the critical role of acetylcholinesterase inhibition.
    Acquas E; Fibiger HC
    J Neurochem; 1998 Mar; 70(3):1088-93. PubMed ID: 9489729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative dopamine-cholinergic mechanisms in the olfactory tubercle and the striatum: effects of metoclopramide.
    Suarez-Roca H; Lovenberg T; Cubeddu LX
    J Pharmacol Exp Ther; 1987 Dec; 243(3):840-51. PubMed ID: 3320346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release.
    Robertson GS; Tham CS; Wilson C; Jakubovic A; Fibiger HC
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1344-51. PubMed ID: 8095550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative feedback regulation of nigrostriatal dopamine release: mediation by striatal D1 receptors.
    Saklayen SS; Mabrouk OS; Pehek EA
    J Pharmacol Exp Ther; 2004 Oct; 311(1):342-8. PubMed ID: 15175419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurokinin1 receptor antagonist CP-99,994 reduces catalepsy produced by the dopamine D2 receptor antagonist raclopride: correlation with extracellular acetylcholine levels in striatum.
    Anderson JJ; Randall S; Chase TN
    J Pharmacol Exp Ther; 1995 Aug; 274(2):928-36. PubMed ID: 7636756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalamic regulation of striatal acetylcholine efflux is both direct and indirect and qualitatively altered in the dopamine-depleted striatum.
    Zackheim J; Abercrombie ED
    Neuroscience; 2005; 131(2):423-36. PubMed ID: 15708484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic regulation of cortical acetylcholine release.
    Day J; Fibiger HC
    Synapse; 1992 Dec; 12(4):281-6. PubMed ID: 1465741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous dopamine facilitates striatal in vivo acetylcholine release by acting on D1 receptors localized in the striatum.
    Consolo S; Girotti P; Russi G; Di Chiara G
    J Neurochem; 1992 Oct; 59(4):1555-7. PubMed ID: 1402904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
    Parker EM; Cubeddu LX
    J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of nicotine-induced acetylcholine release in the rat hippocampus in vivo: evidence for a permissive dopamine synapse.
    Reid RT; Lloyd GK; Rao TS
    Br J Pharmacol; 1999 Jul; 127(6):1486-94. PubMed ID: 10455300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores.
    Parker EM; Cubeddu LX
    J Pharmacol Exp Ther; 1986 Apr; 237(1):193-203. PubMed ID: 3007738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is in vivo striatal acetylcholine output under a tonic inhibitory control by dopamine?
    Imperato A; Obinu MC; Gessa GL
    J Neural Transm Suppl; 1995; 45():91-102. PubMed ID: 8748614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism.
    Abercrombie ED; DeBoer P
    J Neurosci; 1997 Nov; 17(21):8498-505. PubMed ID: 9334422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices.
    Jin S; Johansson B; Fredholm BB
    J Pharmacol Exp Ther; 1993 Nov; 267(2):801-8. PubMed ID: 7902434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for multiple dopamine receptors involved in the modulation of acetylcholine release in the striatum.
    Hársing LG; Vizi ES
    Pol J Pharmacol Pharm; 1985; 37(3):383-96. PubMed ID: 2866504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of Delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by micro opioid and D(1) dopamine receptors.
    Pisanu A; Acquas E; Fenu S; Di Chiara G
    Neuropharmacology; 2006 May; 50(6):661-70. PubMed ID: 16427098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.